Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
4.
Clin Cancer Res ; 23(22): 7047-7058, 2017 Nov 15.
Article in English | MEDLINE | ID: mdl-28912136

ABSTRACT

Purpose: Despite tumor resection being the first-line clinical care for glioblastoma (GBM) patients, nearly all preclinical immune therapy models intend to treat established GBM. Characterizing cytoreductive surgery-induced immune response combined with the administration of immune cytokines has the potential of offering a new treatment paradigm of immune therapy for GBMs.Experimental Design: We developed syngeneic orthotopic mouse GBM models of tumor resection and characterized the immune response of intact and resected tumors. We also created a highly secretable variant of immune cytokine IFNß to enhance its release from engineered mouse mesenchymal stem cells (MSC-IFNß) and assessed whether surgical resection of intracranial GBM tumor significantly enhanced the antitumor efficacy of targeted on-site delivery of encapsulated MSC-IFNß.Results: We show that tumor debulking results in substantial reduction of myeloid-derived suppressor cells (MDSC) and simultaneous recruitment of CD4/CD8 T cells. This immune response significantly enhanced the antitumor efficacy of locally delivered encapsulated MSC-IFNß via enhanced selective postsurgical infiltration of CD8 T cells and directly induced cell-cycle arrest in tumor cells, resulting in increased survival of mice. Utilizing encapsulated human MSC-IFNß in resected orthotopic tumor xenografts of patient-derived GBM, we further show that IFNß induces cell-cycle arrest followed by apoptosis, resulting in increased survival in immunocompromised mice despite their absence of an intact immune system.Conclusions: This study demonstrates the importance of syngeneic tumor resection models in developing cancer immunotherapies and emphasizes the translational potential of local delivery of immunotherapeutic agents in treating cancer. Clin Cancer Res; 23(22); 7047-58. ©2017 AACR.


Subject(s)
Gene Expression Regulation, Neoplastic , Glioblastoma/genetics , Glioblastoma/immunology , Interferon-beta/genetics , Stem Cells/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Animals , Apoptosis/drug effects , Apoptosis/genetics , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Checkpoint Kinase 1/metabolism , Chemotaxis, Leukocyte/immunology , Dendritic Cells/immunology , Dendritic Cells/metabolism , Disease Models, Animal , Female , Glioblastoma/pathology , Glioblastoma/therapy , Humans , Interferon-beta/metabolism , Mice , S Phase Cell Cycle Checkpoints/drug effects , S Phase Cell Cycle Checkpoints/genetics , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
9.
Stem Cells ; 33(2): 589-600, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25346520

ABSTRACT

Pseudomonas exotoxin (PE) potently blocks protein synthesis by catalyzing the inactivation of elongation factor-2 (EF-2). Targeted PE-cytotoxins have been used as antitumor agents, although their effective clinical translation in solid tumors has been confounded by off-target delivery, systemic toxicity, and short chemotherapeutic half-life. To overcome these limitations, we have created toxin-resistant stem cells by modifying endogenous EF-2, and engineered them to secrete PE-cytotoxins that target specifically expressed (interleukin-13 receptor subunit alpha-2) or overexpressed (epidermal growth factor receptor) in glioblastomas (GBM). Molecular analysis correlated efficacy of PE-targeted cytotoxins with levels of cognate receptor expression, and optical imaging was applied to simultaneously track the kinetics of protein synthesis inhibition and GBM cell viability in vivo. The release of IL13-PE from biodegradable synthetic extracellular matrix (sECM) encapsulated stem cells in a clinically relevant GBM resection model led to increased long-term survival of mice compared to IL13-PE protein infusion. Moreover, multiple patient-derived GBM lines responded to treatment, underscoring its clinical relevance. In sum, integrating stem cell-based engineering, multimodal imaging, and delivery of PE-cytotoxins in a clinically relevant GBM model represents a novel strategy and a potential advancement in GBM therapy.


Subject(s)
Bacterial Proteins , Brain Neoplasms/therapy , Drug Resistance/genetics , Exotoxins , Interleukin-13 , Peptide Elongation Factor 2 , Recombinant Fusion Proteins , Stem Cell Transplantation , Stem Cells/metabolism , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Line , Exotoxins/genetics , Exotoxins/metabolism , Genetic Engineering , Heterografts , Humans , Interleukin-13/genetics , Interleukin-13/metabolism , Mice , Peptide Elongation Factor 2/genetics , Peptide Elongation Factor 2/metabolism , Pseudomonas/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Stem Cells/pathology
10.
Nat Rev Cancer ; 14(10): 683-91, 2014 10.
Article in English | MEDLINE | ID: mdl-25176333

ABSTRACT

Stem cell-based therapies are emerging as a promising strategy to tackle cancer. Multiple stem cell types have been shown to exhibit inherent tropism towards tumours. Moreover, when engineered to express therapeutic agents, these pathotropic delivery vehicles can effectively target sites of malignancy. This perspective considers the current status of stem cell-based treatments for cancer and provides a rationale for translating the most promising preclinical studies into the clinic.


Subject(s)
Neoplasms/therapy , Stem Cell Transplantation , Animals , Antineoplastic Agents/administration & dosage , Combined Modality Therapy , Drug Carriers/administration & dosage , Humans , Neoplasms/immunology , Oncolytic Virotherapy , Stem Cells/physiology
11.
Trends Mol Med ; 19(11): 685-94, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24076237

ABSTRACT

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand, or TRAIL, is a promising anticancer agent as it can induce apoptosis in a wide range of cancers whilst generally sparing non-malignant cells. However, the translation of TRAIL into the clinic has been confounded by its short half-life, inadequate delivery methods, and TRAIL-resistant cancer cell populations. In this review, we discuss how TRAIL has been functionalized to diversify its traditional tumor-killing role and novel strategies to facilitate its effective deployment in preclinical cancer models. The successes and failures of the most recent clinical trials using TRAIL agonists are highlighted and we provide a perspective for improving its clinical implementation.


Subject(s)
Neoplasms/drug therapy , TNF-Related Apoptosis-Inducing Ligand/therapeutic use , Animals , Apoptosis/drug effects , Clinical Trials as Topic , Humans , Neoplasms/physiopathology
12.
PLoS One ; 7(11): e49200, 2012.
Article in English | MEDLINE | ID: mdl-23152874

ABSTRACT

We have compared the performance of two Troponin-C-based calcium FRET sensors using fluorescence lifetime read-outs. The first sensor, TN-L15, consists of a Troponin-C fragment inserted between CFP and Citrine while the second sensor, called mTFP-TnC-Cit, was realized by replacing CFP in TN-L15 with monomeric Teal Fluorescent Protein (mTFP1). Using cytosol preparations of transiently transfected mammalian cells, we have measured the fluorescence decay profiles of these sensors at controlled concentrations of calcium using time-correlated single photon counting. These data were fitted to discrete exponential decay models using global analysis to determine the FRET efficiency, fraction of donor molecules undergoing FRET and calcium affinity of these sensors. We have also studied the decay profiles of the donor fluorescent proteins alone and determined the sensitivity of the donor lifetime to temperature and emission wavelength. Live-cell fluorescence lifetime imaging (FLIM) of HEK293T cells expressing each of these sensors was also undertaken. We confirmed that donor fluorescence of mTFP-TnC-Cit fits well to a two-component decay model, while the TN-L15 lifetime data was best fitted to a constrained four-component model, which was supported by phasor analysis of the measured lifetime data. If the constrained global fitting is employed, the TN-L15 sensor can provide a larger dynamic range of lifetime readout than the mTFP-TnC-Cit sensor but the CFP donor is significantly more sensitive to changes in temperature and emission wavelength compared to mTFP and, while the mTFP-TnC-Cit solution phase data broadly agreed with measurements in live cells, this was not the case for the TN-L15 sensor. Our titration experiment also indicates that a similar precision in determination of calcium concentration can be achieved with both FRET biosensors when fitting a single exponential donor fluorescence decay model to the fluorescence decay profiles. We therefore suggest that mTFP-based probes are more suitable for FLIM experiments than CFP-based probes.


Subject(s)
Biosensing Techniques , Calcium/metabolism , Fluorescence Resonance Energy Transfer , Fluorescent Dyes/metabolism , Green Fluorescent Proteins/metabolism , Luminescent Proteins/metabolism , Troponin C/metabolism , Cytosol/metabolism , HEK293 Cells , Humans , Microscopy, Fluorescence , Mutant Proteins/metabolism , Protein Conformation , Reproducibility of Results , Temperature , Time Factors , Titrimetry
13.
Appl Opt ; 50(36): 6583-90, 2011 Dec 20.
Article in English | MEDLINE | ID: mdl-22193187

ABSTRACT

We describe a new light transport model, which was applied to three-dimensional lifetime imaging of Förster resonance energy transfer in mice in vivo. The model is an approximation to the radiative transfer equation and combines light diffusion and ray optics. This approximation is well adopted to wide-field time-gated intensity-based data acquisition. Reconstructed image data are presented and compared with results obtained by using the telegraph equation approximation. The new approach provides improved recovery of absorption and scattering parameters while returning similar values for the fluorescence parameters.


Subject(s)
Algorithms , Fluorescence Resonance Energy Transfer/methods , Optics and Photonics/methods , Animals , Fluorescence , Imaging, Three-Dimensional/methods , Mice , Models, Theoretical , Scattering, Radiation , Tomography, Optical/methods
14.
Biomed Opt Express ; 2(7): 1907-17, 2011 Jul 01.
Article in English | MEDLINE | ID: mdl-21750768

ABSTRACT

Förster resonance energy transfer (FRET) is a powerful biological tool for reading out cell signaling processes. In vivo use of FRET is challenging because of the scattering properties of bulk tissue. By combining diffuse fluorescence tomography with fluorescence lifetime imaging (FLIM), implemented using wide-field time-gated detection of fluorescence excited by ultrashort laser pulses in a tomographic imaging system and applying inverse scattering algorithms, we can reconstruct the three dimensional spatial localization of fluorescence quantum efficiency and lifetime. We demonstrate in vivo spatial mapping of FRET between genetically expressed fluorescent proteins in live mice read out using FLIM. Following transfection by electroporation, mouse hind leg muscles were imaged in vivo and the emission of free donor (eGFP) in the presence of free acceptor (mCherry) could be clearly distinguished from the fluorescence of the donor when directly linked to the acceptor in a tandem (eGFP-mCherry) FRET construct.

15.
J Immunol ; 186(10): 5719-28, 2011 May 15.
Article in English | MEDLINE | ID: mdl-21490154

ABSTRACT

We have previously shown that intranasal (i.n.) administration of a single MHC class II-restricted HY peptide to female mice induces tolerance to up to five additional epitopes expressed on test male grafts, a phenomenon known as linked suppression. In this study, we investigated the molecular mechanisms involved both in the induction phase following peptide administration and during linked suppression after grafting. We report that following initial i.n. administration, peptide is widely disseminated and is presented by functionally immature dendritic cells. These fail to cause optimal stimulation of the responding HY-specific CD4(+) T cells that express genes characteristic of regulatory T cells. Following i.n. peptide plus LPS administration, causing immunization, HY-specific CD4(+) T cells express genes characteristic of activated T cells. We further find that following male skin grafting, HY-specific CD8(+) T cells from peptide-treated tolerant mice display both quantitative and qualitative differences compared with similar cells from untreated mice that reject their grafts. In tolerant mice there are fewer HY-specific CD8(+) cells and they express several genes characteristic of exhausted T cells. Furthermore, associated with specific chemokine receptor and integrin expression, HY-specific CD8(+) T cells show more limited migration from the graft draining lymph node into other tissues.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Graft Survival/immunology , H-Y Antigen/immunology , Peptide Fragments/immunology , Transplantation Tolerance , Administration, Intranasal , Adoptive Transfer , Animals , Cell Movement , Cytokines/genetics , Dendritic Cells/immunology , Female , Flow Cytometry , Gene Expression , H-Y Antigen/administration & dosage , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/immunology , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Molecular Sequence Data , Peptide Fragments/administration & dosage , Polymerase Chain Reaction , Skin Transplantation/immunology
16.
Development ; 138(8): 1521-30, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21427142

ABSTRACT

During development, the growth of the embryo must be coupled to its patterning to ensure correct and timely morphogenesis. In the mouse embryo, migration of the anterior visceral endoderm (AVE) to the prospective anterior establishes the anterior-posterior (A-P) axis. By analysing the distribution of cells in S phase, M phase and G2 from the time just prior to the migration of the AVE until 18 hours after its movement, we show that there is no evidence for differential proliferation along the A-P axis of the mouse embryo. Rather, we have identified that as AVE movements are being initiated, the epiblast proliferates at a much higher rate than the visceral endoderm. We show that these high levels of proliferation in the epiblast are dependent on Nodal signalling and are required for A-P establishment, as blocking cell division in the epiblast inhibits AVE migration. Interestingly, inhibition of migration by blocking proliferation can be rescued by Dkk1. This suggests that the high levels of epiblast proliferation function to move the prospective AVE away from signals that are inhibitory to its migration. The finding that initiation of AVE movements requires a certain level of proliferation in the epiblast provides a mechanism whereby A-P axis development is coordinated with embryonic growth.


Subject(s)
Embryo, Mammalian/cytology , Endoderm/cytology , Viscera/embryology , Animals , Cell Cycle/physiology , Cell Movement/physiology , Cell Proliferation , Embryo, Mammalian/metabolism , Endoderm/metabolism , Gene Expression Regulation, Developmental , Immunohistochemistry , In Situ Hybridization , Mice
17.
PLoS One ; 6(3): e17620, 2011 Mar 18.
Article in English | MEDLINE | ID: mdl-21445260

ABSTRACT

Anterior-posterior axis specification in the mouse requires signalling from a specialised extra-embryonic tissue called the anterior visceral endoderm (AVE). AVE precursors are induced at the distal tip of the embryo and move to the prospective anterior. Embryological and genetic analysis has demonstrated that the AVE is required for anterior patterning and for correctly positioning the site of primitive streak formation by inhibiting Nodal activity. We have carried out a genetic ablation of the Hex-expressing cells of the AVE (Hex-AVE) by knocking the Diphtheria toxin subunit A into the Hex locus in an inducible manner. Using this model we have identified that, in addition to its requirement in the anterior of the embryo, the Hex-AVE sub-population has a novel role between 5.5 and 6.5dpc in patterning the primitive streak. Embryos lacking the Hex-AVE display delayed initiation of primitive streak formation and miss-patterning of the anterior primitive streak. We demonstrate that in the absence of the Hex-AVE the restriction of Bmp2 expression to the proximal visceral endoderm is also defective and expression of Wnt3 and Nodal is not correctly restricted to the posterior epiblast. These results, coupled with the observation that reducing Nodal signalling in Hex-AVE ablated embryos increases the frequency of phenotypes observed, suggests that these primitive streak patterning defects are due to defective Nodal signalling. Together, our experiments demonstrate that the AVE is not only required for anterior patterning, but also that specific sub-populations of this tissue are required to pattern the posterior of the embryo.


Subject(s)
Body Patterning , Endoderm/embryology , Viscera/embryology , Animals , Base Sequence , DNA Primers , Genetic Markers , Homeodomain Proteins/genetics , Mice , Nodal Protein/genetics , Transcription Factors/genetics
18.
Chemphyschem ; 12(3): 609-26, 2011 Feb 25.
Article in English | MEDLINE | ID: mdl-21337485

ABSTRACT

A fluorescence lifetime imaging (FLIM) technology platform intended to read out changes in Förster resonance energy transfer (FRET) efficiency is presented for the study of protein interactions across the drug-discovery pipeline. FLIM provides a robust, inherently ratiometric imaging modality for drug discovery that could allow the same sensor constructs to be translated from automated cell-based assays through small transparent organisms such as zebrafish to mammals. To this end, an automated FLIM multiwell-plate reader is described for high content analysis of fixed and live cells, tomographic FLIM in zebrafish and FLIM FRET of live cells via confocal endomicroscopy. For cell-based assays, an exemplar application reading out protein aggregation using FLIM FRET is presented, and the potential for multiple simultaneous FLIM (FRET) readouts in microscopy is illustrated.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Proteins/analysis , Cell Line , Drug Evaluation, Preclinical , Fluorescent Dyes/chemistry , Green Fluorescent Proteins/chemistry , Humans , Microscopy, Fluorescence , Protein Binding , Rhodamines/chemistry , gag Gene Products, Human Immunodeficiency Virus/analysis
19.
Opt Lett ; 34(18): 2772-4, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19756100

ABSTRACT

We report a three-dimensional time-resolved tomographic imaging technique for localizing protein-protein interaction and protein conformational changes in turbid media based on Förster resonant energy-transfer read out using fluorescence lifetime. This application of "tomoFRET" employs an inverse scattering algorithm utilizing the diffusion approximation to the radiative-transfer equation applied to a large tomographic data set of time-gated images. The approach is demonstrated by imaging a highly scattering cylindrical phantom within which are two thin wells containing cytosol preparations of HEK293 cells expressing TN-L15, a cytosolic genetically encoded calcium Förster resonant energy-transfer sensor. A 10 mM calcium chloride solution was added to one of the wells, inducing a protein conformation change upon binding to TN-L15, resulting in Förster resonant energy transfer and a corresponding decrease in the donor fluorescence lifetime. We successfully reconstruct spatially resolved maps of the resulting fluorescence lifetime distribution as well as of the quantum efficiency, absorption, and scattering coefficients.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Optics and Photonics/methods , Calcium Chloride/pharmacology , Cell Line , Cytosol/metabolism , Diffusion , Humans , Phantoms, Imaging , Protein Conformation , Scattering, Radiation , Silicones/chemistry , Time Factors
20.
Development ; 134(18): 3359-69, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17699604

ABSTRACT

The specification of a subset of epiblast cells to acquire a neural fate constitutes the first step in the generation of the nervous system. Little is known about the signals required for neural induction in the mouse. We have analysed the role of BMP signalling in this process. We demonstrate that prior to gastrulation, Bmp2/4 signalling via Bmpr1a maintains epiblast pluripotency and prevents precocious neural differentiation of this tissue, at least in part by maintaining Nodal signalling. We find that during gastrulation, BMPs of the 60A subgroup cooperate with Bmp2/4 to maintain pluripotency. The inhibition of neural fate by BMPs is independent of FGF signalling, as inhibition of FGF signalling between 5.5 and 7.5 days post-coitum does not block neural differentiation in the mouse embryo. Together, our results demonstrate that inhibition of BMP signalling has a central role during neural induction in mammals and suggest that FGFs do not act as neural inducers in the post-implantation mouse embryo.


Subject(s)
Bone Morphogenetic Protein Receptors, Type I/physiology , Bone Morphogenetic Proteins/metabolism , Cell Differentiation , Nervous System/embryology , Animals , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Protein 7 , Bone Morphogenetic Protein Receptors, Type I/genetics , Cell Differentiation/genetics , Embryo, Mammalian/metabolism , Embryonic Development , Fibroblast Growth Factors/metabolism , Mice , Mice, Mutant Strains , Nervous System/cytology , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Signal Transduction , Transforming Growth Factor beta/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...